Back on June 9th I posted “Another Low Priced Stock to Buy.”  The stock, Precision Biosciences (DTIL) was around 8. It broke out Tues. on news of FDA approval for one of their treatments. Yesterday, it started a pullback after getting extremely overbought. I look for the pullback to last a few more days and fill the gap near 11.5. That would be a great entry point. This company has multiple treatments in different stages of research and trials and has a relationship with Eli Lilly. I strongly expect Lilly will be buying them out sometime in the not too distant future.